221 results on '"Varela, Nelson"'
Search Results
2. Pharmacogenomics: Challenges and Future Perspectives
3. Pharmacogenomics: Genetic Polymorphisms
4. Pharmacokinetic Polymorphisms
5. The close interaction between hypoxia-related proteins and metastasis in pancarcinomas
6. Resolvin D1 reduces expression and secretion of cytokines and monocyte adhesion triggered by Angiotensin II, in rat cardiac fibroblasts
7. Parasite Burden of Trypanosoma cruzi in Whole Blood and Buffy Coat Determined by Real-Time PCR in Individuals with Chronic Chagas Disease
8. Genetic Polymorphisms and Tumoral Mutational Profiles over Survival in Advanced Colorectal Cancer Patients: An Exploratory Study
9. Polymorphisms PSCA rs2294008, IL-4 rs2243250 and MUC1 rs4072037 are associated with gastric cancer in a high risk population
10. NOD1 rs2075820 (p.E266K) polymorphism is associated with gastric cancer among individuals infected with cagPAI-positive H. pylori
11. Pharmacogenomics: Challenges and Future Perspectives
12. Pharmacogenomics: Basis and Milestones
13. Pharmacogenomics: Genetic Polymorphisms
14. Pharmacokinetic Polymorphisms
15. A Multi-Stage Methodology for Long-Term Open-Pit Mine Production Planning under Ore Grade Uncertainty
16. Figure 3 from: Alvarado AT, Muñoz AM, Varela N, Sullón-Dextre L, Pineda M, Bolarte-Arteaga M, Bendezú MR, García JA, Chávez H, Surco-Laos F, Melgar-Merino EJ, Cuba-Garcia PA, Molina-Cabrera A, Pari-Olarte B, Bonifaz-Hernandez M, Panay-Centeno JF, Kong-Chirinos J, Almeida-Galindo J (2023) Pharmacogenetic variants of CYP2C9 and CYP2C19 associated with adverse reactions induced by antiepileptic drugs used in Peru. Pharmacia 70(3): 603-618. https://doi.org/10.3897/pharmacia.70.e109011
17. Figure 4 from: Alvarado AT, Muñoz AM, Varela N, Sullón-Dextre L, Pineda M, Bolarte-Arteaga M, Bendezú MR, García JA, Chávez H, Surco-Laos F, Melgar-Merino EJ, Cuba-Garcia PA, Molina-Cabrera A, Pari-Olarte B, Bonifaz-Hernandez M, Panay-Centeno JF, Kong-Chirinos J, Almeida-Galindo J (2023) Pharmacogenetic variants of CYP2C9 and CYP2C19 associated with adverse reactions induced by antiepileptic drugs used in Peru. Pharmacia 70(3): 603-618. https://doi.org/10.3897/pharmacia.70.e109011
18. Figure 2 from: Alvarado AT, Muñoz AM, Varela N, Sullón-Dextre L, Pineda M, Bolarte-Arteaga M, Bendezú MR, García JA, Chávez H, Surco-Laos F, Melgar-Merino EJ, Cuba-Garcia PA, Molina-Cabrera A, Pari-Olarte B, Bonifaz-Hernandez M, Panay-Centeno JF, Kong-Chirinos J, Almeida-Galindo J (2023) Pharmacogenetic variants of CYP2C9 and CYP2C19 associated with adverse reactions induced by antiepileptic drugs used in Peru. Pharmacia 70(3): 603-618. https://doi.org/10.3897/pharmacia.70.e109011
19. Pharmacogenetic variants of CYP2C9 and CYP2C19 associated with adverse reactions induced by antiepileptic drugs used in Peru
20. Figure 1 from: Alvarado AT, Muñoz AM, Varela N, Sullón-Dextre L, Pineda M, Bolarte-Arteaga M, Bendezú MR, García JA, Chávez H, Surco-Laos F, Melgar-Merino EJ, Cuba-Garcia PA, Molina-Cabrera A, Pari-Olarte B, Bonifaz-Hernandez M, Panay-Centeno JF, Kong-Chirinos J, Almeida-Galindo J (2023) Pharmacogenetic variants of CYP2C9 and CYP2C19 associated with adverse reactions induced by antiepileptic drugs used in Peru. Pharmacia 70(3): 603-618. https://doi.org/10.3897/pharmacia.70.e109011
21. An updated examination of the perception of barriers for pharmacogenomics implementation and the usefulness of drug/gene pairs in Latin America and the Caribbean
22. Editorial: Pharmacogenetics and pharmacogenomics in Latin America: ethnic variability, new insights in advances and perspectives: a RELIVAF-CYTED initiative, Volume II
23. The role of phase I and II genetic polymorphisms, smoking, alcohol and cancer family history, in the risk of developing testicular cancer
24. Frequency of CYP2D6*3 and *4 and metabolizer phenotypes in three mestizo Peruvian populations
25. Pharmacogenetic variants of CYP2C9 and CYP2C19 associated with adverse reactions induced by antiepileptic drugs used in Peru.
26. Editorial: Pharmacogenetics and Pharmacogenomics in Latin America: Ethnic Variability, New Insights in Advances and Perspectives: A RELIVAF-CYTED Initiative
27. Novel Risk Associations between microRNA Polymorphisms and Gastric Cancer in a Chilean Population
28. Figure 1 from: Alvarado AT, Ybañez-Julca R, Muñoz AM, Tejada-Bechi C, Cerro R, Quiñones LA, Varela N, Alvarado CA, Alvarado E, Bendezú MR, García JA (2021) Frequency of CYP2D6*3 and *4 and metabolizer phenotypes in three mestizo Peruvian populations. Pharmacia 68(4): 891-898. https://doi.org/10.3897/pharmacia.68.e75165
29. Figure 2 from: Alvarado AT, Ybañez-Julca R, Muñoz AM, Tejada-Bechi C, Cerro R, Quiñones LA, Varela N, Alvarado CA, Alvarado E, Bendezú MR, García JA (2021) Frequency of CYP2D6*3 and *4 and metabolizer phenotypes in three mestizo Peruvian populations. Pharmacia 68(4): 891-898. https://doi.org/10.3897/pharmacia.68.e75165
30. Frequency of CYP2D6*3 and *4 and metabolizer phenotypes in three mestizo Peruvian populations
31. Effect of CYP3A4, CYP3A5, MDR1 and POR Genetic Polymorphisms in Immunosuppressive Treatment in Chilean Kidney Transplanted Patients
32. Preliminary Pharmacogenomic-Based Predictive Models of Tamoxifen Response in Hormone-dependent Chilean Breast Cancer Patients
33. Retrospective pharmacogenetic analysis of a pediatric patient under anticoagulant treatment: Clinical case
34. Reply to the commentary: Estimating genotype and allele frequencies of the CYP2D6 gene
35. Characterization of the CYP2D6 drug metabolizing phenotypes of the Chilean mestizo population through polymorphism analyses
36. Figure 1 from: Alvarado AT, Muñoz AM, Bartra MS, Valderrama-Wong M, González D, Quiñones LA, Varela N, Bendezú MR, García JA, Loja-Herrera B (2021) Frequency of CYP1A1*2A polymorphisms and deletion of the GSMT1 gene in a Peruvian mestizo population. Pharmacia 68(4): 747-754. https://doi.org/10.3897/pharmacia.68.e71621
37. Frequency of CYP1A1*2A polymorphisms and deletion of the GSMT1 gene in a Peruvian mestizo population
38. Figure 2 from: Alvarado AT, Muñoz AM, Bartra MS, Valderrama-Wong M, González D, Quiñones LA, Varela N, Bendezú MR, García JA, Loja-Herrera B (2021) Frequency of CYP1A1*2A polymorphisms and deletion of the GSMT1 gene in a Peruvian mestizo population. Pharmacia 68(4): 747-754. https://doi.org/10.3897/pharmacia.68.e71621
39. Análisis farmacogenético retrospectivo de una paciente pediátrica en tratamiento anticoagulante: caso clínico
40. Smartphone screen testing, a novel pre-diagnostic method to identify SARS-CoV-2 infectious individuals
41. Author response: Smartphone screen testing, a novel pre-diagnostic method to identify SARS-CoV-2 infectious individuals
42. Pharmacogenetic Associations Between Atazanavir/UGT1A1*28 and Efavirenz/rs3745274 (CYP2B6) Account for Specific Adverse Reactions in Chilean Patients Undergoing Antiretroviral Therapy
43. Additional file 1 of NOD1 rs2075820 (p.E266K) polymorphism is associated with gastric cancer among individuals infected with cagPAI-positive H. pylori
44. Additional file 3 of NOD1 rs2075820 (p.E266K) polymorphism is associated with gastric cancer among individuals infected with cagPAI-positive H. pylori
45. Additional file 6 of NOD1 rs2075820 (p.E266K) polymorphism is associated with gastric cancer among individuals infected with cagPAI-positive H. pylori
46. Additional file 5 of NOD1 rs2075820 (p.E266K) polymorphism is associated with gastric cancer among individuals infected with cagPAI-positive H. pylori
47. Additional file 4 of NOD1 rs2075820 (p.E266K) polymorphism is associated with gastric cancer among individuals infected with cagPAI-positive H. pylori
48. NOD1 rs2075820 (p.E266K) polymorphism is associated with gastric cancer among individuals infected with cagPAI–positive H. pylori
49. In silico Analyses of Immune System Protein Interactome Network, Single-Cell RNA Sequencing of Human Tissues, and Artificial Neural Networks Reveal Potential Therapeutic Targets for Drug Repurposing Against COVID-19
50. A New Insight for the Identification of Oncogenic Variants in Breast and Prostate Cancers in Diverse Human Populations, With a Focus on Latinos
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.